Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Galapagos is van plan een strategische samenwerking aan te gaan met Gilead, na de overname van Ouro Medicines door Gilead De nieuwe partnerstructuur zou aanzienlijk verbeterde financiële voorwaarden...
-
Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms...
-
Daix (France), New York (États-Unis), le 23 mars 2026 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une...
-
Daix (France), New York (United States), March 23, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the...
-
23 mars, 2026 RCI BANQUE : ‘’Mise à disposition des Etats Financiers Consolidés audités 2025’’ Vous trouverez les états financiers consolidés audités de RCI BANQUE au 31 décembre 2025, mis à...
-
Amsterdam, 23 March 2026 EXOR REPORTS €37.1 BILLION GROSS ASSET VALUE AT END-2025 NAV per share decreased by 8.1% compared to a 5.4% increase in the MSCI World IndexPerformance was driven by...
-
Tórshavn, Faroe Islands, 2026-03-23 (GLOBE NEWSWIRE) -- P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) hereby announces an update to the financial calendar for 2026: Referring to press release...
-
Tórshavn, Faroe Islands, 2026-03-23 (GLOBE NEWSWIRE) -- P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) provides update on debt situation. Referring to the announcement issued 30th December 2025 and...
-
On 22 January 2026, Tryg A/S (“Tryg”) announced that the Board of Directors had decided to initiate a share buyback programme of up to DKK 1.0 billion. The share buyback programme is executed in...
-
Disclosure of trading in own shares from March 16 to 20, 2026 Paris – March 23, 2026 Share repurchase program approved by the Shareholders’ Meeting of May 27, 2025. Transaction Details: Publicis...